Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Gains from Investment Securities: 2010-2013

Historic Gains from Investment Securities for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Mar 2013 value amounting to $163,000.

  • Sonoma Pharmaceuticals' Gains from Investment Securities rose 12.41% to $163,000 in Q1 2013 from the same period last year, while for Mar 2013 it was $624,000, marking a year-over-year increase of 39.29%. This contributed to the annual value of $1,000 for FY2023, which is 99.87% down from last year.
  • Sonoma Pharmaceuticals' Gains from Investment Securities amounted to $163,000 in Q1 2013, which was up 3.16% from $158,000 recorded in Q4 2012.
  • Sonoma Pharmaceuticals' Gains from Investment Securities' 5-year high stood at $163,000 during Q1 2013, with a 5-year trough of -$4,000 in Q2 2010.
  • Moreover, its 3-year median value for Gains from Investment Securities was $150,000 (2012), whereas its average is $136,444.
  • Per our database at Business Quant, Sonoma Pharmaceuticals' Gains from Investment Securities spiked by 1,550.00% in 2011 and then declined by 7.05% in 2012.
  • Over the past 4 years, Sonoma Pharmaceuticals' Gains from Investment Securities (Quarterly) stood at -$4,000 in 2010, then spiked by 1,550.00% to $128,000 in 2011, then increased by 23.44% to $158,000 in 2012, then increased by 12.41% to $163,000 in 2013.
  • Its last three reported values are $163,000 in Q1 2013, $158,000 for Q4 2012, and $153,000 during Q3 2012.